Patient-specific signaling signatures predict optimal therapeutic combinations for triple negative breast cancerHeba Alkhatib, Nataly Kravchenko‐Balasha, Jason E. Conage‐Pough et al.|Molecular Cancer|2024Cited by 12
Overexpressed kinetochore genes are used by cancer cells as genome destabilizers and transformation catalystsReem Kamal Aldwaik, Michael Klutstein, Mimi Abo-Ayoub Ashqar et al.|Translational Oncology|2023Cited by 8